This interactive multimedia module, designed for healthcare providers in Europe, highlights treatment as prevention as a strategy to reduce HCV incidence in persons who inject drugs.
This downloadable slideset reviews the importance of treatment as prevention in achievement of HCV elimination goals in Europe and provides practical strategies for implementing treatment and support services in PWID and those in the correctional setting.
Now that clinicians outside of hospital settings can assess and treat HCV in France, which high-risk groups should we target for HCV “microelimination” and how? Here’s my take.
HCV prevalence remains high among PWID and incarcerated individuals in Germany, as barriers to care persist. How can we best provide both HCV treatment and harm reduction services to these key populations? Here’s my take.
Spain has the highest HCV treatment rate among European nations, yet challenges remain for our goal of eliminating HCV by 2030. Read my take on how we should best implement national strategies at the local level in high-priority populations.
Outdated regulatory barriers stand in the way of ready access to DAA therapy in Italy. How can we best reform these policies (eg, complex pretreatment characterization, prescriber restrictions) to treat more PWID and move closer to HCV elimination? Here’s my take.
The promising HCV treatment as prevention (TasP) model has yet to be proven in real-world PWID. Here, we share our experiences, progress, and remaining challenges with evaluating a local HCV TasP program in Tayside, Scotland.
This on-demand audio features expert perspectives on HCV elimination efforts in France and the UK and highlights globally applicable lessons on treatment as prevention.
This on-demand audio features expert perspectives on HCV elimination efforts in Germany and the UK and highlights globally applicable lessons on treatment as prevention.
This on-demand audio features expert perspectives on HCV elimination efforts in Italy and Spain and highlights globally applicable lessons on treatment as prevention.
This on-demand audio features expert perspectives on HCV elimination efforts in Italy and France and highlights globally applicable lessons on treatment as prevention.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.